Detection of DNA damage in sonochemotherapy against cisplatin-resistant human ovarian cancer cells using the modified comet assay

International Journal of Radiation Biology

Volumn 90, Issue 10, 2014, Pages 897-902

  He, Haining ^a,b   Huang, Hong ^a   Yu, Tinghe ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

cisplatin resistance; comet assay; DNA damage; methodology; ovarian cancer; sonochemotherapy

Indexed keywords

CISPLATIN; CYCLOSPORIN A; ANTINEOPLASTIC AGENT; CYCLOSPORIN; DNA;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL DEATH; CELL VIABILITY; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; HUMAN; HUMAN CELL; OVARIAN CANCER CELL LINE; PRIORITY JOURNAL; SONOCHEMOTHERAPY; ULTRASOUND SCANNER; ULTRASOUND THERAPY; DRUG RESISTANCE; ELECTROPORATION; FEMALE; GENETICS; MULTIMODALITY CANCER THERAPY; OVARIAN NEOPLASMS; PATHOLOGY; PROCEDURES; RADIATION RESPONSE; TREATMENT OUTCOME; TUMOR CELL LINE; ULTRASOUND;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; CISPLATIN; COMBINED MODALITY THERAPY; COMET ASSAY; CYCLOSPORINE; DNA DAMAGE; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; ELECTROPORATION; FEMALE; HUMANS; OVARIAN NEOPLASMS; SONICATION; TREATMENT OUTCOME;

EID: 84909630608     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2014.922721     Document Type: Article

References (28)

1. Aouali N, Eddabra L, Macadré J, Morjani H. 2005. Immunosuppressors and reversion of multidrug-resistance. Crit Rev Oncol Hematol 56:61-70.
2. Azhari H. 2010. Basics of biomedical ultrasound for engineers. Hoboken, NJ: John Wiley & Sons Ltd. pp. 153-190.
3. Bisognol G, Cowiel F, Boddy A, Thomas HD, Dick G, Pinkerton CR. 1998. High-dose cyclosporin with etoposide-toxicity and pharmacokinetic interaction in children with solid tumours. Br J Cancer 77:2304-2309.
4. Dhawan A, Bajpayee M, Parmar D. 2009. Comet assay: A reliable tool for the assessment of DNA damage in different models. Cell Biol Toxicol 25:5-32.
5. Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. 2012. Molecular mechanisms of cisplatin resistance. Oncogene 31:1869-1883.
6. Gilbert DC, Chalmers AJ, El-Khamisy SF. 2012. Topoisomerase I inhibition in colorectal cancer: Biomarkers and therapeutic targets. Br J Cancer 106:18-24.
7. He H, Yu T, Zhang Y. 2012. The interaction between a drug and ultrasound in sonochemotherapy against ovarian cancers. Ultraschall Med 33:275-282.
8. th Annu SAS Users Group Int Conf 676-680.
9. Khan A, Manna K, Bose C, Sinha M, Das DK, Kesh SB, Chakrabarty A, Banerji A, Dey S. 2013. Gossypetin, a naturally occurring hexahydroxy flavone, ameliorates gamma radiation-mediated DNA damage. Int J Radiat Biol 89:965-975.
10. Jin ZJ. 2004. About the evaluation of drug combination. Acta Pharmacol Sin 25:146-147.
11. Koñca K, Lankoff A, Banasik A, Lisowska H, Kuszewski T, Góz'dź S, Koza Z, Wojcik A. 2003. A cross-platform public domain PC imageanalysis program for the comet assay. Mutat Res 534:15-20.
12. Liang L, Xie S, Jiang J, Jin H, Li S, Liu J. 2013. The combined effects of hematoporphyrin monomethyl ether-SDT and doxorubicin on the proliferation of QBC939 cell lines. Ultrasound Med Biol 39:146-160.
13. Linghu L, Tan Y, Lou Y, Hu L, Yang H, Yu T. 2013. Nanosecond electric pulses induce DNA breaks in cisplatin-sensitive and -resistant human ovarian cancer cells. Biochem Biophys Res Commun 430:695-699.
14. Miklavčič D, Šemrov D, Mekid H, Mir LM. 2000. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 1523:73-83.
15. Milowska K, Gabryelak T. 2007. Reactive oxygen species and DNA damage after ultrasound exposure. Biomol Eng 24:263-267.
16. Mo S, Coussios CC, Seymour L, Carlisle R. 2012. Ultrasound-enhanced drug delivery for cancer. Expert Opin Drug Deliv 9:1525-1538.
17. Morjani H, Madoulet C. 2010. Immunosuppressors as multidrug resistance reversal agents. Methods Mol Biol 59:433-446.
18. Mutch DG, Herzog TJ, Chen CA, Collins JL. 1992. The effects of cyclosporin A on the lysis of ovarian cancer cells by cisplatin or adriamycin. Gynecol Oncol 47:28-33.
19. Olive PL, Banáth JP. 2006. The comet assay: A method to measure DNA damage in individual cells. Nat Protoc 1:23-29.
20. nd ed. Boca Raton, FL: Chapman & Hall/CRC, Test 11.
21. Stoddart MJ. 2011. WST-8 analysis of cell viability during osteogenesis of human mesenchymal stem cells. Methods Mol Biol 740:21-25.
22. Szerencsi Á, Kubinyi G, Váliczkó É, Juhász P, Rudas G, Mester Á, Jánossy G, Bakos J, Thuróczy G. 2013. DNA integrity of human leukocytes after magnetic resonance imaging. Int J Radiat Biol 89:870-876.
23. Yu T, Bai J, Hu K, Wang Z. 2004. Biological effects of ultrasound exposure on adriamycin-resistant and cisplatin-resistant human ovarian carcinoma cell lines in vitro. Ultrason Sonochem 11:89-94.
24. Yu T, Li S, Zhao J, Mason TJ. 2006a. Ultrasound: A chemotherapy sensitizer. Technol Cancer Res Treat 6:51-60.
25. Yu T, Fan X, Xiong S, Hu K, Wang Z. 2006b. Microbubbles assist goat liver ablation by high intensity focused ultrasound. Eur Radiol 16:1557-1563.
26. Yu T, Zhang Y, He H, Zhou S, Liu Y, Huang P. 2011. Anticancer potency of cytotoxic drugs after exposure to high-intensity focused ultrasound in the presence of microbubbles and hematoporphyrin. Mol Pharm 8:1408-1415.
27. Yu T, Fu X. 2014. Extracorporeal ultrasound-guided high intensity focused ultrasound: Implications from the present clinical trials. Sci World J 2014:537260.
28. Zhou YZ, Chen HZ, Yang QY, Liu SQ, Hou HY. 1996. Establishment of human ovarian cancer cisplatin resistant cell line COC1/DDP and its mechanism of resistance. Natl Med J China 76:680-683.